PPT-Standard 4 Medication Safety

August 2021 Standard 4 Medication Safety The Medication Safety Standard aims to ensure that clinicians safely prescribe dispense and administer appropriate medicines and monitor medicine use It also aims to ensure that consumers are informed about medicines and understand their own medicine needs and risks. MEDICATION SAFETY ALERT ALLERGIES TO SULFONAMIDE ANTIBIOTICS AND CROSS-REACTIVITIESKEY MESSAGES sulfonamides because they contain an the allergies and hypersensitivity. Many other drugs can be cl . Walking the Talk. . Marcia Astuto, RN. Nurse educator / Infection control nurse. William B. Rice Eventide Home. MAstuto@eventidehome.org. Susanne Salem-Schatz, Sc.D.. Program . Director. Appropriate . Medication Order Writing & the “Do Not Use” Abbreviations. To enhance understanding of the linkages between medication safety and communication.. To ensure that all healthcare professional and associated staff are familiar with the “DO NOT USE: Dangerous Abbreviations and Symbols, Dose Designations” Materials from the Manitoba Institute for Patient Safety.. Are Key to . Keeping Kidney Patients Safe. On average, dialysis patients take 6 to 10 different medications each day.. Most dialysis patients report that they only “sometimes” discuss all of their medications with their doctor.. Module 12. Medication Errors. The National Coordinating Council for Medication Error Reporting and Prevention defines a medication error as follows: any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of health care professional, patient, or consumer. By. Tsneem. . Tagelsir. . Khider. Medication safety. What is “medication error”?. Error . . Failure. of a planned action to be completed as intended. Medication error . Any . preventable event . Chapter Topics. Medical errors. Medication errors. Prescription filling process in community and hospital pharmacy practices. Medication error prevention. Medication error reporting systems. Learning Objectives. H. Gwen Bartlett, BS Pharmacy, . PharmD. , . BCPS, BCCCP. Assistant Professor of Pharmacy Practice. Cardiology Specialty. Husson. University. Bangor, ME . 1. Disclosure. I. . have no relevant financial . Welcome and Introductions. 2. Presentation Goals. To raise your awareness of:. how you can help improve patient safety. safe medication use practices . the value of working with your pharmacist. 3. Topics. complications as published by the FDA As of December 2018, the FDA reports that 24 women, out of approximately 3.7 million, have died after taking mifepristone for medication abortion. However, as Philip A Routledge. James Coulson. All Wales Therapeutics and Toxicology Centre. Cardiff, Wales, UK. Case Study. A 44 year-old woman had a urinary tract infection and was prescribed the antibiotic nitrofurantoin for 10 days. Two weeks later she noticed numbness, pins and needles and tingling of the lower limbs up to mid-thigh. She was examined by a neurologist three months later, who stated that this was likely to have been a peripheral neuropathy related to the previous course of nitrofurantoin. She is referred to you (as a clinical pharmacologist) for advice.. Andrew Smith, Lancaster, UK. On behalf of the ESAIC Patient Safety and Quality Committee and the EBA. Adverse drug event ADE. “. An adverse drug event, injuries resulting from medical intervention. Welcome to the monthly web meeting . Wednesday 31. st. August 2022. The meeting will start at 1pm. Web meeting process. Welcome to our monthly meeting using MS Teams. Please use the chat box to comment, share your experiences and ask questions.. Welcome to the monthly web meeting . Wednesday 26. th. April 2023. Web meeting process. Welcome to our monthly meeting using MS Teams. Please use the chat box to comment, share your experiences and ask questions..